Shenzhen Liying Biotechnology Co., Ltd announced that it has received in Angel+ round of funding on May 24, 2024. The transaction included participation from returning investors Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, and Wuxi Best Precision Machinery Co., Ltd. and other institutions such Dandelion (Shenzhen) Pharmaceutical Venture Capital Co., Ltd.